Photodynamic therapy of a transplanted pancreatic cancer model using metamtetrahydroxyphenylchlorin (mTHPC)
1997

Photodynamic Therapy for Pancreatic Cancer in Hamsters

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): P Mlkvy, H Messman, AJ MacRobert, M Pauer, VR Sams, CL Davies, JCM Stewart, SG Bown

Primary Institution: National Medical Laser Centre, The Institute of Surgical Studies, University College London Medical School

Hypothesis

Can photodynamic therapy (PDT) using mTHPC effectively treat pancreatic cancer in a hamster model?

Conclusion

PDT with mTHPC can produce significant zones of necrosis in pancreatic tumors in hamsters, suggesting potential for clinical application.

Supporting Evidence

  • Maximum tumor necrosis was observed at 12.4 mm in diameter with light fractionation.
  • Complications included sealed duodenal perforation in 3 of 16 animals.
  • mTHPC showed preferential uptake in tumors compared to normal tissues.

Takeaway

This study shows that a special light treatment can help kill cancer cells in hamsters with pancreatic cancer, which might help people with similar cancers.

Methodology

Female Syrian golden hamsters were injected with pancreatic cancer cells and treated with mTHPC followed by light exposure to assess tumor necrosis.

Limitations

The study was conducted in hamsters, and results may not directly translate to humans; complications such as duodenal perforation were observed.

Participant Demographics

Female Syrian golden hamsters (100-120 g)

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication